Searched for
NEOVASCULAR AMD
Biocon Biologics secures market entry for Yesafili in USBiocon Biologics has reached a settlement and licensing agreement with Regeneron, clearing the way for the US commercialization of Yesafili...15 Apr, 2025, 10.53 AM IST- Roche launches top selling eye drug Vabysmo in IndiaRoche Pharma India launches Vabysmo, a medication for neovascular age-related macular degeneration and diabetic macular edema in India. The...05 Mar, 2024, 10.14 PM IST
- Biocon Biologics settles patent issue; paves way for launch of biosimilar product in CanadaBiocon Biologics has settled patent disputes with Bayer Inc and Regeneron Pharmaceuticals Inc, enabling the launch of Yesafili, an ophthalm...04 Mar, 2024, 11.47 AM IST
Load More
